BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15880134)

  • 1. Pneumonia caused by Trichosporon pullulans in an autologous peripheral blood stem cell transplant recipient: possible misidentification.
    Mele G; Musci M; Musto C; D'Amato L; Traficante A; Di Renzo N
    Bone Marrow Transplant; 2005 Jun; 35(12):1219-20. PubMed ID: 15880134
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient.
    Nettles RE; Nichols LS; Bell-McGuinn K; Pipeling MR; Scheel PJ; Merz WG
    Clin Infect Dis; 2003 Feb; 36(4):E63-6. PubMed ID: 12567323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blastoschizomyces capitatus pneumonia in an immuno-competent female.
    Gill PK; Gill JS
    Indian J Tuberc; 2011 Apr; 58(2):88-9. PubMed ID: 21644397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding "Trichosporon pullulans infection in 2 patients with chronic granulomatous disease".
    Holland SM; Shea YR; Kwon-Chung J
    J Allergy Clin Immunol; 2004 Jul; 114(1):205-6; author reply 206. PubMed ID: 15282941
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy.
    Mahdi-Rogers M; Kazmi M; Ferner R; Hughes RA; Renaud S; Steck AJ; Fuhr P; Halter J; Gratwohl A; Tyndall A
    J Peripher Nerv Syst; 2009 Jun; 14(2):118-24. PubMed ID: 19691534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation.
    Demirer T; Ayli M; Dagli M; Fen T; Haznedar R; Ustael N; Ustun T; Oymak A; Ozdel O; Muftuoglu O
    Bone Marrow Transplant; 2002 Nov; 30(10):703-4. PubMed ID: 12420210
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation.
    Meyer E; Beyersmann J; Bertz H; Wenzler-Röttele S; Babikir R; Schumacher M; Daschner FD; Rüden H; Dettenkofer M;
    Bone Marrow Transplant; 2007 Feb; 39(3):173-8. PubMed ID: 17245425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation.
    Plensa E; Gallardo E; Ribera JM; Batlle M; Oriol A; Costa J
    Bone Marrow Transplant; 2004 Jan; 33(1):119-20. PubMed ID: 14704665
    [No Abstract]   [Full Text] [Related]  

  • 10. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation.
    Schaffel R; Portugal R; Maiolino A; Nucci M
    Bone Marrow Transplant; 2004 Jan; 33(1):117. PubMed ID: 14704664
    [No Abstract]   [Full Text] [Related]  

  • 11. Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia.
    Termuhlen AM; Klopfenstein K; Olshefski R; Rosselet R; Yeager ND; Soni S; Gross TG
    Pediatr Blood Cancer; 2008 Oct; 51(4):521-4. PubMed ID: 18493994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants?
    Labonté L; Iqbal T; McDiarmid S; Bence-Bruckler I; Huebsch L; Allan D
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):132-3. PubMed ID: 18158970
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
    Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
    Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis.
    González-Vicent M; Díaz MA; Colmenero I; Sevilla J; Madero L
    Transpl Infect Dis; 2008 Jun; 10(3):193-6. PubMed ID: 18069930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
    Kohno K; Nagafuji K; Tsukamoto H; Horiuchi T; Takase K; Aoki K; Henzan H; Kamezaki K; Takenaka K; Miyamoto T; Teshima T; Harada M; Akashi K
    Transpl Infect Dis; 2009 Aug; 11(4):318-23. PubMed ID: 19453993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
    Laurenti L; Tarnani M; Chiusolo P; La Torre G; Garzia M; Zollino M; Zini G; Balducci M; Leone G; Sica S
    Clin Transplant; 2008; 22(2):191-9. PubMed ID: 18339139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichosporon pullulans as a complication of chronic granulomatous disease in a patient undergoing immunosuppressive therapy for inflammatory bowel disease.
    Lestini BJ; Church JA
    Pediatr Infect Dis J; 2006 Jan; 25(1):87-9. PubMed ID: 16395115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.